AOB Pharma and Biorasi to Partner to run Phase 2b in Moderate to Severe Acne

Following encouraging earlier-phase clinical data, the Company is advancing its acne trial ahead of schedule while maintaining atopic dermatitis global Phase 3 timeline. CAMBRIDGE, Mass., July 1, 2026 /PRNewswire/ -- AOB Pharma, Inc. ("AOBiome"), a leading clinical-stage biotechnology...